You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORKA Sale Disclosure
Agarwal Arjun · SEC Form 4 · Filed Jun 15, 2026
Sale
Calculated transaction value
$27.53K
Agarwal Arjun Senior Vice President, Finance
ORKA
Oruka Therapeutics
ORKA
Transaction date
Jun 15, 2026
Public filing date
Jun 15, 2026
Filing lag
Filed same day
ORKA daily price context
Close on/before transaction
$68.86
Jun 15, 2026
First close after public filing
$67.71
Jun 16, 2026
30-day return after filing
+27.97%
Through Jul 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 395 shares @ $69.69
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0000907654-26-000064
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$837.21K
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oruka Therapeutics, Inc. ORKA Current | Sale | Jun 15, 2026 | $27.53K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Jun 12, 2026 | $50.18K |
| Oruka Therapeutics, Inc. ORKA | Sale | Jun 12, 2026 | $127.05K |
| Oruka Therapeutics, Inc. ORKA | Sale | Jun 12, 2026 | $303.15K |
| Oruka Therapeutics, Inc. ORKA | Sale | Jun 12, 2026 | $229.31K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Jun 12, 2026 | $0 |
| Oruka Therapeutics, Inc. ORKA | Exercise | Jun 12, 2026 | $100K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Jun 12, 2026 | $0 |